Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3025]
News [6111]
Articles [120]
Editorials [18]
Conferences [179]
elearning [32]
ASCO 2023: Vorasidenib delays disease progression or death in grade 2 glioma with IDH mutation
ASCO 2023: Vorasidenib delays disease progression or death in grade 2 glioma with IDH mutation
ASCO 2023: Nivolumab reduces risk of disease progression or death in untreated hodgkin lymphoma compared to brentuximab
ASCO 2023: Nivolumab reduces risk of disease progression or death in untreated hodgkin lymphoma compared to...
ASCO 2023: Radiation can be safely omitted in select patients with locally advanced rectal cancer
ASCO 2023: Radiation can be safely omitted in select patients with locally advanced rectal cancer
ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
ASCO 2023: Osimertinib after surgery significantly improves survival in patients with resected EGFR-mutated non-small cell lung cancer
ASCO 2023: Osimertinib after surgery significantly improves survival in patients with resected EGFR-mutated non...
ASCO 2023: Study may provide clues to treating colorectal cancer more effectively in younger patients
ASCO 2023: Study may provide clues to treating colorectal cancer more effectively in younger patients
ASCO 2023: For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
ASCO 2023: For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
ASCO 2023: Targeted therapy induces responses in HER2-amplified biliary tract cancer
ASCO 2023: Targeted therapy induces responses in HER2-amplified biliary tract cancer
ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade
ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit...
ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit
ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation